Concepedia

Paul R. Kunk

PR

Statistics

Publications

11

Citations

345

H-Index

11

Active since

2016

Affiliations

University of Virginia(Current)

University of Virginia Health System

Dana-Farber Cancer Institute

Georgetown University

University of Utah

Paul R. Kunk is an author at University of Virginia specializing in medicine, oncology, and cancer immunotherapy.

ORCID

Publications per year

2016–2022

11

Publications

11

Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature

Joshua E. Reuss, Paul R. Kunk, Anne M. Stowman et al. · Journal for ImmunoTherapy of Cancer · 2016 · 96 citations · Full text

, , +17

Risk of Major Bleeding with Ibrutinib

Paul R. Kunk, Surabhi Palkimas, Jeremy Sen et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 63 citations

, , +6

Direct oral anticoagulants in hypercoagulable states

Paul R. Kunk, Jacqueline T. Brown, Melissa McShane et al. · Journal of Thrombosis and Thrombolysis · 2016 · 36 citations

, , +13

Mismatch Repair Protein Deficiency/Microsatellite Instability Is Rare in Cholangiocarcinomas and Associated With Distinctive Morphologies

Jennifer Y. Ju, Megan E. Dibbern, Mani S. Mahadevan et al. · American Journal of Clinical Pathology · 2019 · 34 citations · Full text

, , +17

Major Bleeding with Ibrutinib: More Than Expected

Paul R. Kunk, Joesph Mock, Michael Devitt et al. · Blood · 2016 · 21 citations

, , +8

1–5 of 11